Seref Alpsoy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seref Alpsoy has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Aydın Akyüz
Namık Kemal University, Turkey
11 shared publications Dursun Cayan Akkoyun
5 shared publicationsDursun Çayan Akkoyun
4 shared publicationsHasan Degirmenci
Department of Cardiology, Tekirdag State Hospital, Tekirdag, Turkey
4 shared publications- Birol Topçu
Namık Kemal University
3 shared publications - Demet Ozkaramanli Gur
Namik Kemal Univ, Dept Cardiol, Fac Med, Tekirdag, Turkey
2 shared publications
Latest Publications
- Open Access
- 12 August 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (32) , e29881
Effects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study
Background: We have aimed at exposing left ventricular diastolic functions and the presence of known genetic mutations for familial erythrocytosis, in patients who exhibit idiopathic erythrocytosis. Methods: Sixty-four patients with idiopathic erythrocytosis (mean age, 46.4 ± 2.7 years) and 30 age-matched healthy subjects were prospectively evaluated. The regions of interest of the erythropoietin receptor, hemoglobin beta-globin, von Hippel-Lindau, hypoxia-inducible factor 2 alpha, and Egl-9 family hypoxia-inducible factor genes were amplified by PCR. Left ventricular (LV) mass was measured by M-mode and 2-dimensional echocardiography. LV diastolic functions were assessed by conventional echocardiography and tissue Doppler imaging. Results: As a result of genetic analyses, genetic mutations for familial erythrocytosis were detected in 5 patients. It has been observed in our study that the risk of cardiovascular disorders is higher in patients. Interventricular septum thickness, left atrial diameter, and some diastolic function parameters such as deceleration time and isovolumetric relaxation time have been found to be significantly higher in idiopathic erythrocytosis group than in the controls. Conclusion: This study has shown that LV diastolic functions were impaired in patients with idiopathic erythrocytosis. In this patient group with increased risk of cardiovascular disorders, the frequent genetic mutations have been detected in 5 patients only. Therefore, further clinical investigations are needed as novel genetic mutations may be discovered in patients with idiopathic erythrocytosis because of cardiovascular risk.
- 12 August 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (32) , e29881
Open AccessEffects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study
Background: We have aimed at exposing left ventricular diastolic functions and the presence of known genetic mutations for familial erythrocytosis, in patients who exhibit idiopathic erythrocytosis. Methods: Sixty-four patients with idiopathic erythrocytosis (mean age, 46.4 ± 2.7 years) and 30 age-matched healthy subjects were prospectively evaluated. The regions of interest of the erythropoietin receptor, hemoglobin beta-globin, von Hippel-Lindau, hypoxia-inducible factor 2 alpha, and Egl-9 family hypoxia-inducible factor genes were amplified by PCR. Left ventricular (LV) mass was measured by M-mode and 2-dimensional echocardiography. LV diastolic functions were assessed by conventional echocardiography and tissue Doppler imaging. Results: As a result of genetic analyses, genetic mutations for familial erythrocytosis were detected in 5 patients. It has been observed in our study that the risk of cardiovascular disorders is higher in patients. Interventricular septum thickness, left atrial diameter, and some diastolic function parameters such as deceleration time and isovolumetric relaxation time have been found to be significantly higher in idiopathic erythrocytosis group than in the controls. Conclusion: This study has shown that LV diastolic functions were impaired in patients with idiopathic erythrocytosis. In this patient group with increased risk of cardiovascular disorders, the frequent genetic mutations have been detected in 5 patients only. Therefore, further clinical investigations are needed as novel genetic mutations may be discovered in patients with idiopathic erythrocytosis because of cardiovascular risk.
- 13 June 2021
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (7) , 671-676
The relationship between mean platelet volume and reverse dipping blood pressure pattern in patients with essential hypertension
An association between increased mean platelet volume (MPV) and cardiovascular events is well established. Recent studies suggest that a nondipper blood pressure pattern is closely related to incre...
- 13 June 2021
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (7) , 671-676
The relationship between mean platelet volume and reverse dipping blood pressure pattern in patients with essential hypertension
An association between increased mean platelet volume (MPV) and cardiovascular events is well established. Recent studies suggest that a nondipper blood pressure pattern is closely related to incre...
- 29 July 2020
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (1) , 42-48
Assessment of salusin alpha and salusin beta levels in patients with newly diagnosed dipper and non-dipper hypertension
The pathophysiology of non-dipper hypertension has not been clarified. The relationship between salusins with atherosclerosis and hypertension has gained attention in recent years. The aim of this paper is to investigate whether salusins are associated with circadian blood pressure, left ventricular mass index, and diastolic functions in newly diagnosed hypertensives. The study included 88 newly diagnosed hypertensive individuals. Twenty-four-hour ambulatory blood pressure monitoring and echocardiographic examinations were performed. The patients were assigned to dipper hypertension (n = 41) and non-dipper hypertension (n = 47) groups based on the ambulatory blood pressure monitoring results according to the presence of ≥ a 10% decrease in nighttime blood pressure values or not. Serum salusin α and β levels were determined by electrochemiluminescence immunological test method. Compared to dipper hypertension, non-dipper hypertension group demonstrated lower salusin α levels (1818.71 ± 221.67 vs 1963 ± 200.75 pg/mL, p = .002), mitral E/A, septal E’/A’ and higher salusin β levels (576.24 ± 68.15 vs 516.13 ± 90.7 pg/ml, p = .001) and left ventricular mass index. Multivariate logistic regression analysis revealed salusin-α (OR 0.474, 95% CI 0.262 to 0.986, p = .001), salusin-β (OR 2.550, 95% CI 2.123 to 2.991, p = .018), and left ventricular mass index (OR 2.620, 95% CI 2.124 to 2.860, p = .011) as independent predictors of non-dipper hypertension. As candidate markers to predict non-dipper hypertension, decreased salusin α, and increased salusin β levels may mediate crosstalk between sympathetic and parasympathetic systems and indicate poor cardiovascular prognosis in hypertension.
- 29 July 2020
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (1) , 42-48
Assessment of salusin alpha and salusin beta levels in patients with newly diagnosed dipper and non-dipper hypertension
The pathophysiology of non-dipper hypertension has not been clarified. The relationship between salusins with atherosclerosis and hypertension has gained attention in recent years. The aim of this paper is to investigate whether salusins are associated with circadian blood pressure, left ventricular mass index, and diastolic functions in newly diagnosed hypertensives. The study included 88 newly diagnosed hypertensive individuals. Twenty-four-hour ambulatory blood pressure monitoring and echocardiographic examinations were performed. The patients were assigned to dipper hypertension (n = 41) and non-dipper hypertension (n = 47) groups based on the ambulatory blood pressure monitoring results according to the presence of ≥ a 10% decrease in nighttime blood pressure values or not. Serum salusin α and β levels were determined by electrochemiluminescence immunological test method. Compared to dipper hypertension, non-dipper hypertension group demonstrated lower salusin α levels (1818.71 ± 221.67 vs 1963 ± 200.75 pg/mL, p = .002), mitral E/A, septal E’/A’ and higher salusin β levels (576.24 ± 68.15 vs 516.13 ± 90.7 pg/ml, p = .001) and left ventricular mass index. Multivariate logistic regression analysis revealed salusin-α (OR 0.474, 95% CI 0.262 to 0.986, p = .001), salusin-β (OR 2.550, 95% CI 2.123 to 2.991, p = .018), and left ventricular mass index (OR 2.620, 95% CI 2.124 to 2.860, p = .011) as independent predictors of non-dipper hypertension. As candidate markers to predict non-dipper hypertension, decreased salusin α, and increased salusin β levels may mediate crosstalk between sympathetic and parasympathetic systems and indicate poor cardiovascular prognosis in hypertension.
- Open Access
- 6 April 2017
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 14 (2) , 30-33
Association of coronary artery disease severity and disulphide/native thiol ratio
- 6 April 2017
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 14 (2) , 30-33
Open AccessAssociation of coronary artery disease severity and disulphide/native thiol ratio
- 1 June 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117, S84
PP-124 Predictors of Successful Recanalization and Cost of Chronic Total Occlusions: Single Center Experience
- 1 June 2016
- Published by Elsevier in The American Journal of Cardiology
- Vol. 117, S84
PP-124 Predictors of Successful Recanalization and Cost of Chronic Total Occlusions: Single Center Experience
- 1 April 2016
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 17 (1)
Sa? Sinüs Valsalva’dan Ç?kan Sol Ana Koroner Arter Anomalisi
Öz Sağ sinüs Valsalva’dan çıkan sol ana koroner arter anomalisi, oldukça nadir görülen bir konjenital anomalidir. Tamamen semptomsuz olabildiği gibi, egzersiz ile oluşan göğüs ağrısı ve bayılma, miyokart enfarktüsü ve ani ölüm gibi ciddi klinik tablolar ile de ortaya çıkabilir. Yazımızda, sol ana koroner arterin sağ sinüs Valsalva’dan çıkış anomalisi sunulmaktadır.
- 1 April 2016
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 17 (1)
Sa? Sinüs Valsalva’dan Ç?kan Sol Ana Koroner Arter Anomalisi
Öz Sağ sinüs Valsalva’dan çıkan sol ana koroner arter anomalisi, oldukça nadir görülen bir konjenital anomalidir. Tamamen semptomsuz olabildiği gibi, egzersiz ile oluşan göğüs ağrısı ve bayılma, miyokart enfarktüsü ve ani ölüm gibi ciddi klinik tablolar ile de ortaya çıkabilir. Yazımızda, sol ana koroner arterin sağ sinüs Valsalva’dan çıkış anomalisi sunulmaktadır.
- 1 June 2015
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 20 (3) , 144-149
Serum neurokinin B levels in newly diagnosed nondipper hypertensive patients
Cardiovascular diseases are more common in patients with nondipper hypertension (NDHT) compared with those with dipper hypertension (DHT). The aim of this study is to evaluate the serum neurokinin B levels in DHT and NDHT patients.The study population included newly diagnosed hypertensive patients who were not under antihypertensive treatment. A total of 77 patients were evaluated with ambulatory blood pressure monitoring and divided into two groups: NDHT (n=42) and DHT (n=35). Plasma neurokinin B levels were measured using the ELISA method.Serum neurokinin B levels were significantly higher in the NDHT group compared with the DHT group [254 (180-888) and 207 (116-752) pg/ml, respectively; P=0.024]. There is a positive correlation between the mean night-time systolic blood pressure and plasma neurokinin levels (r=0.590; P<0.001). On regression analysis, neurokinin B level was only found to be related to the mean night-time systolic blood pressure (unstandardized β=-22.02±9.59; P<0.001).Plasma neurokinin B level is higher in patients with NDHT, indicating an unfavorable cardiovascular prognosis. There is a need for further studies that search for the relation between serum neurokinin B levels and NDHT.
- 1 June 2015
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 20 (3) , 144-149
Serum neurokinin B levels in newly diagnosed nondipper hypertensive patients
Cardiovascular diseases are more common in patients with nondipper hypertension (NDHT) compared with those with dipper hypertension (DHT). The aim of this study is to evaluate the serum neurokinin B levels in DHT and NDHT patients.The study population included newly diagnosed hypertensive patients who were not under antihypertensive treatment. A total of 77 patients were evaluated with ambulatory blood pressure monitoring and divided into two groups: NDHT (n=42) and DHT (n=35). Plasma neurokinin B levels were measured using the ELISA method.Serum neurokinin B levels were significantly higher in the NDHT group compared with the DHT group [254 (180-888) and 207 (116-752) pg/ml, respectively; P=0.024]. There is a positive correlation between the mean night-time systolic blood pressure and plasma neurokinin levels (r=0.590; P<0.001). On regression analysis, neurokinin B level was only found to be related to the mean night-time systolic blood pressure (unstandardized β=-22.02±9.59; P<0.001).Plasma neurokinin B level is higher in patients with NDHT, indicating an unfavorable cardiovascular prognosis. There is a need for further studies that search for the relation between serum neurokinin B levels and NDHT.
- Open Access
- 21 May 2015
- Published by Genel Tip Dergisi in Genel Tip Dergisi
- Vol. 25 (1) , 14
İleri kalp yetersizliği hastalarında levosimendanın eritrosit dağılım genişliği üzerine etkisi
- 21 May 2015
- Published by Genel Tip Dergisi in Genel Tip Dergisi
- Vol. 25 (1) , 14
Open Accessİleri kalp yetersizliği hastalarında levosimendanın eritrosit dağılım genişliği üzerine etkisi
- 25 November 2014
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 400 (1-2) , 207-212
Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
Psoriasis is a disease that can contribute to a risk of atherosclerosis. In several studies, impaired endothelial dysfunction (ED) is correlated with psoriasis. Serum YKL-40 is a new inflammatory biomarker of vascular damage, like ED and cardiovascular diseases. The aim of the study was to compare relevance of serum YKL-40 levels in psoriasis patients and healthy subjects according to ED diagnosis and identifiable cardiovascular risk factors. Sixty (31 female, 29 male) patients with plaque psoriasis, and 30 (18 female, 12 male) healthy controls were selected according to whether they had at least one or no identifiable risk factors for cardiovascular disease. All subjects were evaluated ultrasonographically for endothelial function and diagnosed as with or without ED and all groups compared for serum YKL-40 levels. YKL-40 levels of psoriatic patients with ED were higher than healthy controls with ED (P = P < 0.05). But in healthy controls, there were no differences. In comparison of cardiovascular risk-positive (RP) patients and RP healthy subjects, YKL-40 levels were higher in RP patients (P = <0.05). The elevation of plasma YKL-40 in psoriasis can be associated not only with inflammation of the disease, but also with ED. YKL-40 can be used as a marker for predicting and preventing cardiovascular diseases in RP psoriatic patients with age above 40.
- 25 November 2014
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 400 (1-2) , 207-212
Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
Psoriasis is a disease that can contribute to a risk of atherosclerosis. In several studies, impaired endothelial dysfunction (ED) is correlated with psoriasis. Serum YKL-40 is a new inflammatory biomarker of vascular damage, like ED and cardiovascular diseases. The aim of the study was to compare relevance of serum YKL-40 levels in psoriasis patients and healthy subjects according to ED diagnosis and identifiable cardiovascular risk factors. Sixty (31 female, 29 male) patients with plaque psoriasis, and 30 (18 female, 12 male) healthy controls were selected according to whether they had at least one or no identifiable risk factors for cardiovascular disease. All subjects were evaluated ultrasonographically for endothelial function and diagnosed as with or without ED and all groups compared for serum YKL-40 levels. YKL-40 levels of psoriatic patients with ED were higher than healthy controls with ED (P = P < 0.05). But in healthy controls, there were no differences. In comparison of cardiovascular risk-positive (RP) patients and RP healthy subjects, YKL-40 levels were higher in RP patients (P = <0.05). The elevation of plasma YKL-40 in psoriasis can be associated not only with inflammation of the disease, but also with ED. YKL-40 can be used as a marker for predicting and preventing cardiovascular diseases in RP psoriatic patients with age above 40.
- Open Access
- 15 July 2014
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 11 (3)
Effect of Obesity on Endothelial Function and Subclinical Atherosclerosis in Children
- 15 July 2014
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 11 (3)
Open AccessEffect of Obesity on Endothelial Function and Subclinical Atherosclerosis in Children